Results 171 to 180 of about 19,420 (199)

Report of the Working Party on Acquired Inhibitors of Coagulation: Studies of the “Lupus” Anticoagulant

Thrombosis and Haemostasis, 1983
D Green, Cecil Hougie, F J Kazmier, Klaus Lechner, P.M. Mannucci, C. R. Rizza, Sultan Y   +6 more
openalex   +3 more sources

Fibrinolytic parameters and natural inhibitors of blood coagulation in patients with acquired lupus anticoagulant: relation to clinical thrombosis or/and foetal loss

Fibrinolysis, 1994
F. Gougbran, S. Abolouz, Ramsis Neven, Ahmed Elgohary, Emne Ali Abdallah, Hassan A. El‐Shahaly   +5 more
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

[Lupus anticoagulant-hypoprothrombinemia syndrome with a false-positive test for coagulation factor inhibitors].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2013
We report a case of a 1-year-old boy diagnosed with lupus anticoagulant-hypoprothrombinemia syndrome (LA-HPS), which is a rare disorder. His initial presentation of sinusitis was accompanied by hemorrhagic episodes including ecchymoses and epistaxis 6 months after antibiotic therapy.
Shingo, Morinaga, Yoko, Ide, Masaru, Kusumoto, Mika, Ogata, Kazutaka, Takaki, Emiko, Matsumoto   +5 more
openaire   +2 more sources

[Circulating lupus coagulation inhibitor in two sisters, one with disseminated lupus erythematosus and the other with immunologic thrombocytopenic purpura].

La Revue de medecine interne, 1993
Familial cases of lupus anticoagulant were rarely described. We report the observation of two sisters with lupus anticoagulant, one with thrombocytopenic purpura and the other with systemic lupus erythematosus.
J, Constans, A, Le Hérissier, C, Vergnes, R, Roudaut, P, Durandet, P, Gosse, M, Dallocchio   +6 more
openaire   +1 more source

Antiphospholipid Antibodies Accelerate Plasma Coagulation by Inhibiting Annexin-V Binding to Phospholipids: A “Lupus Procoagulant” Phenomenon

, 1998
Jacob H. Rand, Xiao-Xuan Wu, Harry A.M. Andree, J. B. Alexander Ross, E. V. Rusinova, Mayra G. Gascon-Lema, C. Calandri, Peter C. Harpel   +7 more
openalex   +2 more sources

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors, Christiane Angermann Angermann, John R Teerlink   +2 more
exaly  

The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment

Nature Reviews Clinical Oncology, 2023
Nicholas Turner
exaly  

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

Nature Medicine, 2022
Andreas Mackensen, Sebastian Boeltz
exaly